Name:Mao Wei
Post:Director
Telephone:
Email:
Scopes of Responsibility:Take full charge of hospital administration, quali
Resume:
Resume:
Male, graduated from Zhejiang University with a doctorate degree, Level-II Professor of Cardiovascular Medicine, Chief Physician and Doctoral Supervisor.
He is a Young and Middle-aged Experts with Outstanding Contributions in Zhejiang, Leading Health Talent in Zhejiang, Academic Leader of the National Key Clinical Specialty (cardiovascular medicine) and Multidisciplinary Interdisciplinary Innovation Team of Zhejiang Association of Integrative Medicine, enjoying the special allowance of the State Council.
He started to work in August 1988 and once served as the Director of the First Affiliated Hospital and the First Clinical Medical College of Zhejiang Chinese Medical University, and Director (concurrently) of Zhejiang Rehabilitation Hospital and the First Affiliated Rehabilitation Hospital of Zhejiang Chinese Medical University (Xixi Branch of Zhejiang Provincial Hospital of Chinese Medicine). Since November 2022, he has taken up his current position. He is also an Expert Member of Zhejiang Science and Technology Ethics Committee, Director of Zhejiang Key Laboratory for Diagnosis and Treatment of Integrative Chinese and Western Medicine for the Diagnosis and Treatment of Circulatory Diseases, Director of Research Center for Prevention and Control of Cardiovascular and Cerebrovascular Diseases of Zhejiang Province, Chairman of Ethics Expert Committee of Zhejiang Medical Research Institute, Director of Ethics Quality Control Center of Zhejiang Medical Research Institute, Member of Academic Committee of National Clinical Research Center for Chinese Medicine Cardiology, and Vice Chairman of the Alliance for Innovation and Promotion of National TCM Diagnosis and Treatment Mode of Glucolipid Metabolic Disorders, Fellow of the American College of Cardiology, Editorial Board Member of Hypertension (Chinese Edition), Chinese Journal of Integrated Traditional and Western Medicine and Chinese Journal of Heart Failure and Cardiomyopathy, Review Editor in Frontiers in Cardiovascular Medicine Pharmacology and Drug Discovery, Executive Editor-in-Chief of Journal of Prevention and Treatment of Cardiovascular Diseases. He is also Vice President of Cardiovascular Emergency Branch of China Association for Disaster & Emergency Rescue Medicine, Vice Chairman of Health Preservation Committee of China Association of Integrative Medicine, Vice President of Lifestyle Medicine Branch of Chinese Health Association, Standing Committee Member of Cardiovascular Committee of China Association of Integrative Medicine, Vice Chairman of Cardiac Intervention Committee of Doctor Society of Integrative Medicine of Chinese Medical Doctor Association, Standing Committee Member of Precision Medicine Branch on Cardiovascular Diseases of China International Exchange and Promotion Association for Medical and Health Care, Member of Endovascology Committee of Chinese Medical Doctor Association, Member of Heart Failure Group of Cardiovascular Society of Chinese Medical Association, Co-chairman of Yangtze River Delta Heart Failure Center Alliance, Vice President of Zhejiang Hospital Association, Designate Chairman of Cardiovascular Society of Zhejiang Medical Association, Vice Chairman of Steering Committee for Teaching of Clinical Medicine and Stomatology in Universities of Zhejiang Province, President of Doctor Society of Integrative Medicine of Zhejiang Medical Doctor Association, Vice President of Cardiovascular Physician Branch of Zhejiang Physician Association, Vice Chairman of Interventional Cardiovascular Branch of Zhejiang Medical Association.
He has been engaged in cardiovasology for more than 30 years, specializing in the diagnosis and treatment of various cardiovascular diseases and emergency rescue of acute and critical diseases, with profound attainments in the field of interventional cardiology. He has completed more than 6,000 cases of various cardiac interventional surgeries. Mainly engaged in basic and clinical research on coronary heart disease, atrial fibrillation and heart failure. He presided over 1 National Key R&D Project, 4 projects supported by the National Natural Science Foundation of China and 5 major S&T projects at the provincial and ministerial levels. He won 2 second prizes of S&T Progress Award of the People's Government of Zhejiang Province, 1 second prize of S&T Progress Award from the Chinese Association of Integrative Medicine, and 3 first prizes of Zhejiang Medicine and Health and Zhejiang Traditional Chinese Medical S&T Award. He has obtained 2 national invention patents, 2 utility model patents and 2 national software copyrights, authored more than 10 national guidelines such as 2024 Guidelines for the Diagnosis and Treatment of Heart Failure in China, published more than 100 papers in SCI and other journals, participated in the compilation of more than 10 monographs, and cultivated more than 20 postdoctoral, doctoral and master's candidates in cardiovasology.